Back to Global NewsPublished: 23 Feb 2026Download AppJoin TelegramWhy C4 Therapeutics' MOMENTUM Trial May Be a Game‑Changer for MM Investors#C4 Therapeutics#cemsidomide#multiple myeloma#biopharma#clinical trials#investmentDownload AppJoin CommunityShare Article